WallStreetZenWallStreetZen

NASDAQ: ELTX
Elicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Elicio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter DemuthChief Scientific Officer2025-12-09362$4.41
$1.60kBuy

1 of 1

ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELTX insiders and whales buy or sell their stock.

ELTX Shareholders

What type of owners hold Elicio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky28.38%5,416,212$80.43MInsider
Eisaabc LLC14.36%2,740,978$40.70MInsider
Itzhak Goldberg8.84%1,687,986$25.07MInsider
Victor F. Ganzi5.13%978,698$14.53MInsider
Knoll Capital Management LLC3.31%630,915$9.37MInstitution
Vanguard Capital Management LLC2.72%518,638$7.70MInstitution
Balyasny Asset Management LP1.28%244,814$3.64MInstitution
Jay Venkatesan0.95%180,534$2.68MInsider
Geode Capital Management LLC0.71%135,164$2.01MInstitution
Renaissance Technologies LLC0.64%121,631$1.81MInstitution

1 of 3

ELTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELTX13.83%59.76%Net Buying
NVCT17.04%42.64%Net Buying
BCYC53.66%43.65%Net SellingNet Selling
NAUT38.18%61.82%Net SellingNet Selling
RNAC14.41%85.59%Net Buying
View Top Biotech Stocks

Elicio Therapeutics Stock Ownership FAQ

Who owns Elicio Therapeutics?

Elicio Therapeutics (NASDAQ: ELTX) is owned by 13.83% institutional shareholders, 59.76% Elicio Therapeutics insiders, and 26.41% retail investors. Yekaterina Chudnovsky is the largest individual Elicio Therapeutics shareholder, owning 5.42M shares representing 28.38% of the company. Yekaterina Chudnovsky's Elicio Therapeutics shares are currently valued at $80.43M.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.